RS58325B1 - Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom - Google Patents

Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom

Info

Publication number
RS58325B1
RS58325B1 RS20190090A RSP20190090A RS58325B1 RS 58325 B1 RS58325 B1 RS 58325B1 RS 20190090 A RS20190090 A RS 20190090A RS P20190090 A RSP20190090 A RS P20190090A RS 58325 B1 RS58325 B1 RS 58325B1
Authority
RS
Serbia
Prior art keywords
subcoat
proteinaceous
enteric coated
multiparticulate composition
coated multiparticulate
Prior art date
Application number
RS20190090A
Other languages
English (en)
Inventor
Fred Hassan
Syed Shah
Original Assignee
Zx Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zx Pharma Llc filed Critical Zx Pharma Llc
Publication of RS58325B1 publication Critical patent/RS58325B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RS20190090A 2013-04-23 2013-09-23 Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom RS58325B1 (sr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361815073P 2013-04-23 2013-04-23
US201361880294P 2013-09-20 2013-09-20
PCT/US2013/061141 WO2014175916A1 (en) 2013-04-23 2013-09-23 Enteric coated multiparticulate composition with proteinaceous subcoat
EP13882940.3A EP2988824B1 (en) 2013-04-23 2013-09-23 Enteric coated multiparticulate composition with proteinaceous subcoat

Publications (1)

Publication Number Publication Date
RS58325B1 true RS58325B1 (sr) 2019-03-29

Family

ID=51792243

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20190090A RS58325B1 (sr) 2013-04-23 2013-09-23 Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom

Country Status (21)

Country Link
US (7) US8895086B2 (sr)
EP (2) EP2872123B1 (sr)
JP (3) JP5869735B2 (sr)
KR (2) KR101616679B1 (sr)
CN (2) CN105263480B (sr)
AU (2) AU2013387667B2 (sr)
BR (2) BR112015026283B1 (sr)
CA (2) CA2881992C (sr)
CY (1) CY1121582T1 (sr)
DK (1) DK2988824T3 (sr)
ES (2) ES2706152T3 (sr)
HR (1) HRP20190210T1 (sr)
HU (1) HUE042996T2 (sr)
LT (1) LT2988824T (sr)
MX (2) MX2015014915A (sr)
PL (2) PL2988824T3 (sr)
PT (2) PT2872123T (sr)
RS (1) RS58325B1 (sr)
RU (2) RU2647462C2 (sr)
SI (1) SI2988824T1 (sr)
WO (3) WO2014175916A1 (sr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
EP2900224A1 (en) 2012-09-26 2015-08-05 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
RS58325B1 (sr) 2013-04-23 2019-03-29 Zx Pharma Llc Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom
KR20180080189A (ko) 2015-09-01 2018-07-11 퍼스트 웨이브 바이오, 인코포레이티드 이상 염증 반응과 연관된 질환을 치료하기 위한 방법 및 조성물
US10588864B2 (en) 2016-03-11 2020-03-17 Gateway Pharmaceuticals LLC Pharmaceutical compositions for colon-specific delivery
CN109310638A (zh) 2016-05-06 2019-02-05 医师印章有限责任公司 缬草组合物和相关方法
KR102568459B1 (ko) 2016-10-26 2023-08-22 에스엘 주식회사 차량용 램프 제어 장치
CN107049992A (zh) * 2017-05-31 2017-08-18 盛林 一种egcg微丸胶囊及其制备方法
EP3697398A1 (en) 2017-10-16 2020-08-26 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castration-resistant prostate cancer
CN109864982A (zh) * 2019-03-22 2019-06-11 大连医诺生物股份有限公司 表没食子儿茶素没食子酸酯微囊粉及其制备方法
JP2021003024A (ja) * 2019-06-26 2021-01-14 アリメント工業株式会社 徐放性被覆食品粉体集合体及びその製造方法
US20230102999A1 (en) 2020-01-10 2023-03-30 First Wave Bio, Inc. Deuterated niclosamide
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
WO2021188564A1 (en) 2020-03-16 2021-09-23 First Wave Bio, Inc. Methods of treating covid-19 with a niclosamide compound
KR102608047B1 (ko) * 2020-12-29 2023-12-01 주식회사 우제아이엠 역류성 식도질환 또는 기능성 소화불량의 예방 또는 개선을 위한 균형영양식품 조성물
EP4274554A1 (en) * 2021-01-08 2023-11-15 Société des Produits Nestlé S.A. Oral solid cannabinoid oil composition for treating central nervous system disorders

Family Cites Families (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1811777A (en) 1924-06-19 1931-06-23 Howards & Sons Ltd Process for making synthetic menthol
US2366749A (en) 1942-08-29 1945-01-09 Burton T Bush Inc Process for making synthetic menthol
US3515781A (en) 1967-10-12 1970-06-02 Johnson & Johnson Cold capsule
JPS521819A (en) 1975-06-05 1977-01-08 Nippon Tokushu Toryo Kk Acoustic lining material for vehicle
US4080552A (en) 1976-09-22 1978-03-21 Facet Enterprises, Inc. Hybrid blocking oscillator for an electromagnetic fuel pump
EP0015334B1 (en) 1977-08-04 1982-05-19 J.B. Tillott Limited Carminative preparations containing peppermint oil or its active components
JPS61176535A (ja) * 1985-01-31 1986-08-08 Morishita Jintan Kk 腸溶性製剤
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US4808413A (en) 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
IT1243193B (it) 1990-08-10 1994-05-24 Medea Res Srl Composizioni farmaceutiche orali a base di melatonina
US5418010A (en) 1990-10-05 1995-05-23 Griffith Laboratories Worldwide, Inc. Microencapsulation process
US5169754A (en) * 1990-10-31 1992-12-08 Coulter Corporation Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same
DE122007000073I1 (de) 1991-05-09 2008-01-31 Neurim Pharma 1991 Melatonin enthaltene Arzneimittel
JP3015607B2 (ja) 1991-10-16 2000-03-06 信越化学工業株式会社 フェロモン製剤を用いた交信撹乱方法
US7070806B2 (en) 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5397573A (en) 1993-06-04 1995-03-14 The Procter & Gamble Company Laxative compositions
US5417010A (en) * 1993-08-09 1995-05-23 Ecer; Gunes M. Light weight seeding sheet
US5688510A (en) 1993-11-18 1997-11-18 Nippon Shinyaku Co. Ltd. Process for producing stable medicinal composition, and pharmaceutical preparation
US6469044B1 (en) 1995-02-01 2002-10-22 Neurim Pharmaceuticals (1991) Ltd. Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
US5840332A (en) 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
JP2001524131A (ja) 1997-05-09 2001-11-27 セイジ、ファーマスーティカルズ、インク 安定な経口医薬品剤形
JPH1147581A (ja) 1997-07-30 1999-02-23 Takasago Internatl Corp 徐放性カプセル及びその製造方法
FR2771292B1 (fr) 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
US6365185B1 (en) * 1998-03-26 2002-04-02 University Of Cincinnati Self-destructing, controlled release peroral drug delivery system
US6673126B2 (en) 1998-05-14 2004-01-06 Seiko Epson Corporation Multiple chamber fabrication equipment for thin film transistors in a display or electronic device
PT2263660T (pt) 1998-05-18 2017-12-19 Takeda Pharmaceuticals Co Comprimidos de desintegração oral
US6602521B1 (en) 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
JP2000247870A (ja) 1999-02-24 2000-09-12 Isp Japan Kk ウィスカー析出が抑制された固形状製剤及びその製造方法
US8545880B2 (en) 1999-02-26 2013-10-01 Andrx Pharmaceuticals, Llc Controlled release oral dosage form
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
CA2376261A1 (en) 1999-06-09 2000-12-14 Mochida Pharmaceutical Co., Ltd. System for release in lower gastrointestinal tract
BR0013720A (pt) 1999-09-02 2002-07-23 Nostrum Pharmaceuticals Inc Formulação em pelota de liberação controlada
US6627223B2 (en) 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
US6458384B2 (en) 2000-02-23 2002-10-01 Impetus Ag Pharmaceutical with predetermined activity profile
DE50011907D1 (de) 2000-03-04 2006-01-26 Cognis Ip Man Gmbh Mikrokapseln
US6306435B1 (en) 2000-06-26 2001-10-23 Yung Shin Pharmaceutical Industrial Co. Ltd. Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
US6423349B1 (en) 2000-08-24 2002-07-23 Baxter International, Inc. Therapeutic nutrient composition for pre and post elective surgery
GB0025208D0 (en) 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
FR2816507B1 (fr) 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
US20020114832A1 (en) 2000-12-11 2002-08-22 Dr. Willmar Schwabe Gmbh & Co. Pharmaceutical preparation comprising peppermint oil and caraway oil in delayed release form
US20030143272A1 (en) 2001-03-14 2003-07-31 Waterman Kenneth C. Pharmaceutical tablet and process for making thereof
CN100335133C (zh) 2001-11-22 2007-09-05 森下仁丹株式会社 非胶凝状的胶囊膜组合物和使用其所形成的胶囊
US20060009465A1 (en) 2002-01-18 2006-01-12 Dale Edgar Treatment of sleep disorders using sleep target modulators
JP4429590B2 (ja) * 2002-02-08 2010-03-10 株式会社協和ウェルネス ユビキノン含有水可溶性組成物
AU2003220551A1 (en) 2002-03-26 2003-10-13 Euro-Celtique S.A. Sustained-release gel coated compositions
US7115282B2 (en) 2002-04-17 2006-10-03 Salvona Ip Llc Multi component controlled release system for anhydrous cosmetic compositions
US6919348B2 (en) * 2002-05-02 2005-07-19 Edward T. Wei Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
DE10224087A1 (de) 2002-05-31 2003-12-11 Symrise Gmbh & Co Kg Kompaktiertes Menthol
US20040062778A1 (en) 2002-09-26 2004-04-01 Adi Shefer Surface dissolution and/or bulk erosion controlled release compositions and devices
MXPA05003524A (es) * 2002-10-01 2005-10-04 Banner Pharmacaps Inc Preparaciones entericas.
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
AU2003263162B2 (en) 2002-10-24 2009-05-07 Immupharm A/S Pharmaceutical compositions comprising flavonoids and menthol
WO2004037232A1 (en) 2002-10-24 2004-05-06 Micap Plc. Targeted delivery
RU2005130103A (ru) 2003-03-26 2006-03-20 Вм. Ригли Дж. Компани (Us) Кондитерский продукт, покрытый оболочкой с быстрым высвобождением ароматизатора
US6737470B1 (en) 2003-04-04 2004-05-18 Bridgestone Corporation Curable sealant composition
CA2539051C (en) * 2003-09-19 2014-08-12 Penwest Pharmaceuticals Co. Delayed release dosage forms
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
AU2004308962A1 (en) 2003-12-24 2005-07-14 Sepracor Inc. Melatonin combination therapy for improving sleep quality
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
US20050181047A1 (en) 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements
US20050202079A1 (en) 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
EP1746980B1 (en) * 2004-05-07 2011-11-02 Nycomed GmbH Pharmaceutical dosage form comprising pellets as well as its manufacturing process
JP5154924B2 (ja) 2004-05-11 2013-02-27 エガレット エイ／エス ジェランガムを含む膨張可能な投与形態
US20050281876A1 (en) 2004-06-18 2005-12-22 Shun-Por Li Solid dosage form for acid-labile active ingredient
DE102004036437A1 (de) 2004-07-27 2006-03-23 Röhm GmbH & Co. KG Multipartikuläre Arzneiform für wenig lösliche Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
ITMI20041689A1 (it) 2004-09-01 2004-12-02 Bojidar Mihaylov Stankov Nuove formulazioni di rilascio controllato contenenti 5-idrossitriptofano e triptofano
ATE397442T1 (de) * 2004-11-18 2008-06-15 Bristol Myers Squibb Co Magensaftresistent beschichtetes pellet mit ixabepilon
US8535640B1 (en) 2005-01-04 2013-09-17 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
US8361439B1 (en) 2005-01-04 2013-01-29 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
US8574544B1 (en) 2005-01-04 2013-11-05 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
US8337811B1 (en) 2005-01-04 2012-12-25 Gp Medical, Inc. Pharmaceutical composition of nanoparticles
JP5282208B2 (ja) 2005-03-16 2013-09-04 シムライズ アーゲー メントール含有固体組成物
US9149439B2 (en) * 2005-03-21 2015-10-06 Sandoz Ag Multi-particulate, modified-release composition
JP2008534531A (ja) 2005-03-29 2008-08-28 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 調節物質の送達に影響を及ぼすマトリックスを有するペレットを有する多粒子の医薬剤形
US20060257469A1 (en) 2005-04-05 2006-11-16 Bulka Yochanan R Enhanced indoleamine and catecholamine bio-availability via catechin inhibition of L-Dopa decarboxylase
KR20080005575A (ko) * 2005-04-28 2008-01-14 에자이 알앤드디 매니지먼트 가부시키가이샤 안정화 조성물
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US20060280795A1 (en) 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
WO2007012857A1 (en) 2005-07-28 2007-02-01 University Of Hull Topical formulations containing sporopollenin
US20070048366A1 (en) 2005-08-26 2007-03-01 Jen-Chi Chen Gelatin-based coatings having improved durability
JP2007197378A (ja) 2006-01-27 2007-08-09 Kowa Co 糖衣製剤
US20070292510A1 (en) 2006-06-19 2007-12-20 Hugh Huang Enteric coated particles containing an active ingredient
WO2008057802A2 (en) * 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
JP5201819B2 (ja) 2006-11-22 2013-06-05 エスエス製薬株式会社 固形組成物
KR20090091321A (ko) 2006-11-28 2009-08-27 마리누스 파마슈티컬스 나노입자 제형, 이의 제조방법 및 이의 용도
AR063983A1 (es) 2006-11-28 2009-03-04 Wyeth Corp Formulacion de liberacion controlada de agonistas y antagonistas de piperazina -piperidina del receptor 5-ht1a que tienen una disolucion intestinal mejorada
US20080139510A1 (en) 2006-12-07 2008-06-12 Abe Rose Treatment of migraine headaches with sublingual amino acids
EP1953625A1 (en) 2007-02-02 2008-08-06 Melik Gencel Peripheral inputting device for computers
CA2683436C (en) 2007-04-11 2016-07-26 John A. Mccarty Melatonin tablet and methods of preparation and use
WO2008134807A1 (en) 2007-05-04 2008-11-13 The University Of Sydney Method for manufacturing a porous polymer matrix
US20090004281A1 (en) 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system
WO2009007749A2 (en) 2007-07-09 2009-01-15 Astrazeneca Ab Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases
US8048921B2 (en) 2007-09-18 2011-11-01 Ronald Kramer Amino acid compounds
US8969400B2 (en) 2007-10-01 2015-03-03 Duke University Pharmaceutical compositions of 5-hydroxytryptophan and serotonin-enhancing compound
GB0724550D0 (en) * 2007-12-18 2008-01-30 Univ Hull Formulations
US20090238905A1 (en) * 2008-03-20 2009-09-24 Symrise, Inc. Inflammation reducing action of synergistic mixtures of bisabolol and ginger extracts
US20090246301A1 (en) 2008-03-31 2009-10-01 Ehrenpreis Ben Z Method for treating irritable bowel syndrome and other functional gastrointestinal disorders
DE102008023345B4 (de) 2008-05-13 2014-12-04 Lts Lohmann Therapie-Systeme Ag Filmförmige Zubereitung mit öligen Substanzen zur oralen Verabreichung
CN101596166B (zh) 2008-06-04 2011-08-17 永信药品工业(昆山)有限公司 阿司匹林肠溶微丸
AU2009258120B2 (en) * 2008-06-10 2014-11-27 Teva Pharmaceutical Industries, Ltd. Rasagiline soft gelatin capsules
US20110053866A1 (en) 2008-08-12 2011-03-03 Biovail Laboratories International (Barbados) S.R.L. Pharmaceutical compositions
US20120128764A1 (en) * 2009-02-23 2012-05-24 Aptalis Pharmatech, Inc. Controlled-release compositions comprising a proton pump inhibitor
AU2010262738A1 (en) 2009-05-20 2011-10-13 Lingual Consegna Pty Ltd Buccal and/or sublingual therapeutic formulation
EP2305742B1 (en) 2009-10-01 2017-02-22 Symrise AG Spherical core-shell-particle
WO2011046609A2 (en) 2009-10-15 2011-04-21 Appleton Papers Inc. Encapsulation
US9050264B2 (en) * 2009-11-07 2015-06-09 University Of Iowa Research Foundation Cellulose capsules and methods for making them
WO2011111027A2 (en) 2010-03-11 2011-09-15 Dexcel Pharma Technologies Ltd. Oral dispersible delayed release tablet formulation
WO2011146078A1 (en) 2010-05-21 2011-11-24 Board Of Regents, The University Of Texas System Encapsulated particles for enteric release
JP2010189443A (ja) 2010-06-07 2010-09-02 Ss Pharmaceut Co Ltd 揮散防止型固形製剤およびその製造方法
BR112013012184B1 (pt) 2010-11-16 2022-07-12 Provimi North America, Inc Suplemento de ração para gado
BE1019142A3 (fr) * 2011-01-21 2012-03-06 Vesale Pharma S A Substance probiotique microencapsulee.
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
TR201808978T4 (tr) * 2011-02-11 2018-07-23 Zx Pharma Llc Çok partiküllü l-mentol formülasyonları ve ilgili yöntemler.
JP2014517843A (ja) 2011-05-24 2014-07-24 テバ ファーマシューティカル インダストリーズ リミティド 医薬組成物用の圧縮コア
US20120301546A1 (en) 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
US20120315337A1 (en) * 2011-06-07 2012-12-13 Shah Syed Multiparticulate 5-htp compositions and related methods
WO2012170488A1 (en) * 2011-06-07 2012-12-13 Zx Pharma, Llc Multiparticulate s-adenosylmethionine compositions and related methods
DE102012001731A1 (de) * 2012-01-20 2013-07-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Systemische Darreichungsformen mit kontrollierter Freisetzung und verbesserter Stabilität
JP6227546B2 (ja) 2012-10-26 2017-11-08 田辺三菱製薬株式会社 メントールウィスカーの析出を抑制する方法
US20140178468A1 (en) 2012-12-24 2014-06-26 Ranbaxy Laboratories Limited Multiparticulate extended-release composition of mesalamine
RS58325B1 (sr) 2013-04-23 2019-03-29 Zx Pharma Llc Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom
JP2015024986A (ja) 2013-06-20 2015-02-05 大正製薬株式会社 固形製剤

Also Published As

Publication number Publication date
ES2616701T3 (es) 2017-06-14
JP6105761B2 (ja) 2017-03-29
WO2014175917A1 (en) 2014-10-30
WO2014175916A1 (en) 2014-10-30
CN105142726B (zh) 2020-02-07
SI2988824T1 (sl) 2019-02-28
JP2015534582A (ja) 2015-12-03
CN105263480A (zh) 2016-01-20
US9717696B2 (en) 2017-08-01
AU2013387678B2 (en) 2015-04-16
CA2881992A1 (en) 2014-10-30
KR20150139961A (ko) 2015-12-14
RU2647462C2 (ru) 2018-03-15
WO2014175852A1 (en) 2014-10-30
US8895086B2 (en) 2014-11-25
EP2872123A4 (en) 2016-01-20
EP2988824A1 (en) 2016-03-02
US11826475B2 (en) 2023-11-28
US20140314860A1 (en) 2014-10-23
KR101616679B1 (ko) 2016-04-28
RU2606593C1 (ru) 2017-01-10
LT2988824T (lt) 2019-02-25
PL2988824T3 (pl) 2019-04-30
US10420730B2 (en) 2019-09-24
US9192583B2 (en) 2015-11-24
BR112015026283B1 (pt) 2023-04-25
AU2013387667B2 (en) 2016-08-04
US20220071912A1 (en) 2022-03-10
US20160038429A1 (en) 2016-02-11
CA2909591C (en) 2017-03-28
CA2881992C (en) 2016-11-22
RU2015149770A (ru) 2017-05-26
US20160022597A1 (en) 2016-01-28
WO2014175917A8 (en) 2014-12-18
JP2016056189A (ja) 2016-04-21
US20150050352A1 (en) 2015-02-19
AU2013387667A1 (en) 2015-10-29
PT2988824T (pt) 2019-01-30
AU2013387678A1 (en) 2015-02-26
PL2872123T3 (pl) 2017-06-30
US20150044294A1 (en) 2015-02-12
BR112015026283A2 (sr) 2017-09-05
EP2872123A1 (en) 2015-05-20
BR112015006499A2 (pt) 2017-07-04
PT2872123T (pt) 2017-03-15
ES2706152T3 (es) 2019-03-27
EP2872123B1 (en) 2017-01-04
MX2015005913A (es) 2015-09-08
JP2016517867A (ja) 2016-06-20
US9572782B2 (en) 2017-02-21
HRP20190210T1 (hr) 2019-04-05
MX2015014915A (es) 2016-03-07
JP5869735B2 (ja) 2016-02-24
CA2909591A1 (en) 2014-10-30
CN105142726A (zh) 2015-12-09
CY1121582T1 (el) 2020-05-29
KR101787225B1 (ko) 2017-10-18
MX344705B (es) 2017-01-04
HUE042996T2 (hu) 2019-07-29
DK2988824T3 (en) 2019-01-14
US11207273B2 (en) 2021-12-28
EP2988824A4 (en) 2017-02-01
CN105263480B (zh) 2018-08-28
EP2988824B1 (en) 2018-11-07
US20190307701A1 (en) 2019-10-10
KR20150042233A (ko) 2015-04-20

Similar Documents

Publication Publication Date Title
HRP20190210T1 (hr) Enterički premazani multipartikulatni pripravak s proteinskim podslojem
HK1220741A1 (zh) 納米層壓塗層
EP2967283A4 (en) GRIPPING DEVICE WITH MAGNETICALLY CONTROLLED POSITIONING
EP2963503A4 (en) LIGHT POWER SHARING ELEMENT
GB201305935D0 (en) Scheduling
EP3066168A4 (en) Fluoropolymer coatings comprising aziridine compounds
SG11201510139VA (en) Coating composition
GB201522041D0 (en) Coated fabrics
EP2980165A4 (en) COATING COMPOSITION
HK1222874A1 (zh) 塗料組合物
HK1218494A1 (zh) 抗-反流營養組合物
EP2949713A4 (en) COATING COMPOSITION
GB201317959D0 (en) Controlling application launch
IL240575A0 (en) Enteric coated pill
EP2980164A4 (en) COATING COMPOSITION
EP3023096A4 (en) Soft capsule coating
GB201318192D0 (en) Flux Applicator
EP2971689A4 (en) CONFIGURATION WITH MULTIPLE COATINGS
SG11201507647TA (en) Advanced bond coat
HK1215447A1 (zh) 塗料組合物
HK1218395A1 (zh) 包衣組合物
EP2980163A4 (en) COATING COMPOSITION
PL2833346T3 (pl) Przedmiot powleczony
ZA201404640B (en) Coating composition
GB201311332D0 (en) Grease-repellent coating